EPO and hepatocellular carcinoma: Importantly, EPO/EPOR levels correlated well with angiogenesis and progression of patients with hepatocellular carcinoma, neuroblastoma, squamous cell carcinoma of the tongue, melanoma, and gastric adenocarcinoma (115–120).